Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake. | Bioinorg Chem Appl | 2022 | 36620349 | PubTator, text mining | PubMed |
| Genotype Value Decomposition: Simple Methods for the Computation of Kernel Statistics. | Adv Genet (Hoboken) | 2022 | 36620199 | PubTator, text mining | PubMed |
| Ameliorative Effect of Structurally Divergent Oleanane Triterpenoid, 3-Epifriedelinol from Ipomoea batatas against BPA-Induced Gonadotoxicity by Targeting PARP and NF-κB Signaling in Rats. | Molecules | 2022 | 36615482 | PubTator, text mining | PubMed |
| Pharmacodynamic Modeling to Evaluate the Impact of Cimetidine, an OCT2 Inhibitor, on the Anticancer Effects of Cisplatin. | Cells | 2022 | 36611850 | PubTator, text mining | PubMed |
| Rescue of Misfolded Organic Cation Transporter 3 Variants. | Cells | 2022 | 36611832 | PubTator, text mining | PubMed |
| Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models. | Front Pharmacol | 2022 | 36582520 | PubTator, text mining | PubMed |
| Molecular Modeling Targeting the ACE2 Receptor with Cannabis sativa's Active Ingredients for Antiviral Drug Discovery against SARS-CoV-2 Infections. | Bioinform Biol Insights | 2022 | 36582392 | PubTator, text mining | PubMed |
| Research Progress of Population Pharmacokinetic of Metformin. | Biomed Res Int | 2022 | 36578804 | PubTator, text mining | PubMed |
| Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China. | Front Genet | 2022 | 36568374 | PubTator, text mining | PubMed |
| Current Update on Transcellular Brain Drug Delivery. | Pharmaceutics | 2022 | 36559214 | PubTator, text mining | PubMed |
| In Vitro Assessment on Designing Novel Antibiofilms of Pseudomonas aeruginosa Using a Computational Approach. | Molecules | 2022 | 36558064 | PubTator, text mining | PubMed |
| A Review: Meridianins and Meridianins Derivatives. | Molecules | 2022 | 36557848 | PubTator, text mining | PubMed |
| Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study. | Metabolites | 2022 | 36557240 | PubTator, text mining | PubMed |
| A Historical Misconception in Clinical Trials of Drugs for Cancer-Age Grouping. | J Pers Med | 2022 | 36556219 | PubTator, text mining | PubMed |
| Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry. | Int J Mol Sci | 2022 | 36555761 | PubTator, text mining | PubMed |
| Exacerbation of Cisplatin Cellular Toxicity by Regulation of the Human Organic Cation Transporter 2 through Angiotensin II. | Int J Mol Sci | 2022 | 36555515 | PubTator, text mining | PubMed |
| Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis. | Int J Mol Sci | 2022 | 36555470 | PubTator, text mining | PubMed |
| Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in Human and Mouse Organic Cation Transporter OCT2. | Int J Mol Sci | 2022 | 36555439 | PubTator, text mining | PubMed |
| Natural Sympathomimetic Drugs: From Pharmacology to Toxicology. | Biomolecules | 2022 | 36551221 | PubTator, text mining | PubMed |
| The Nephrotoxicity of Drugs Used in Causal Oncological Therapies. | Curr Oncol | 2022 | 36547174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=19